Close Menu

NEW YORK (GenomeWeb) – GenePeeks, a computational genomics company focused on disease risk analysis, said today that it has signed an exclusive distribution agreement with India's Core Diagnostics.

Under the agreement, Core Diagnostics will exclusively offer GenePeeks' preconception screen and advanced analytics platform in 29 states and seven union territories in India.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times Magazine examines gender discrimination at the Salk Institute.

Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.

A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.

In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.